Arovella CEO and Managing Director Michael Baker tells JustStocks Video the company achieved a critical milestone in the June quarter by completing process development to define a clinic-ready manufacturing process for ALA-101 and the CAR-iNKT cell platform.
CEO Dr Michael Baker’s interview with JustStocks
Previous
Previous
TechKnow Invest presentation
Next
Next